The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Elevated Liver Function Tests in Type 2 Diabetes
Open accessAbstract
IN BRIEF Individuals with type 2 diabetes have a higher incidence of liver function test abnormalities than individuals who do not have diabetes. Mild chronic elevations of transaminases often reflect underlying insulin resistance. Elevation of transaminases within three times the upper limits of normal is not a contraindication for starting oral antidiabetic or lipid-modifying therapy. In contrast, antidiabetic agents have generally been shown to decrease alanine aminotransferase levels as tighter blood glucose levels are achieved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
SHIMOMURA, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00009-5 · Cited by 855
Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1002/hep.1840380427 · Cited by 751
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726
Vozarova, B., Stefan, N., Lindsay, R. S., Saremi, A., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1889 · Cited by 717
Daniel, S. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00507-9 · Cited by 354
Wannamethee, G., Ebrahim, S., & Gerald Shaper, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117699 · Cited by 334
Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDM
Perry, I. J., Wannamethee, S. G., & Shaper, A. G. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.732 · Cited by 319
Ohlson, L.-O., Larsson, B., Bj�rntorp, P., Eriksson, H., Sv�rdsudd, K., Welin, L., Tibblin, G., & Wilhelmsen, L. (1988) · Diabetologia · doi:10.1007/bf00277480 · Cited by 316
Skelly, M. M., James, P. D., & Ryder, S. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00094-0 · Cited by 310
Liver disease and diabetes mellitus.
Na, B., Herrine, S. K., & Rubin, R. A. (2001) · PubMed · Cited by 299
Increased Risk of Type 2 Diabetes in Noncirrhotic Patients With Chronic Hepatitis C Virus Infection
Knobler, H., Schihmanter, R., Zifroni, A., Fenakel, G., & Schattner, A. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.355 · Cited by 292
Grove, J., Daly, A. K., Bassendine, M. F., & Day, C. P. (1997) · Hepatology · doi:10.1002/hep.510260119 · Cited by 287
Regulation of gene expression by insulin
O'Brien, R. M., & Granner, D. K. (1991) · Biochemical Journal · doi:10.1042/bj2780609 · Cited by 285
High Prevalence of Hepatitis C Virus Infection in Diabetic Patients
Simó, R., Hernández, C., Genescà, J., Jardí, R., & Mesa, J. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.998 · Cited by 275
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
Writing Committee Members:, Pasternak, R. C., Smith, S. C., Bairey-Merz, C. N., Grundy, S. M., Cleeman, J. I., & Lenfant, C. (2002) · Stroke · doi:10.1161/01.str.0000034125.94759.41 · Cited by 257
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200111000-00029 · Cited by 243
Evaluation of Liver Function in Type 2 Diabetic Patients During Clinical Trials
Lebovitz, H. E., Kreider, M., & Freed, M. I. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.815 · Cited by 218
Snow, V. T., Aronson, M. D., Hornbake, E. R., Mottur-Pilson, C., & Weiss, K. B. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00012 · Cited by 153
Liver Function Tests in Diabetic Patients
Salmela, P. I., Sotaniemi, E. A., Niemi, M., & Mäentausta, O. (1984) · Diabetes Care · doi:10.2337/diacare.7.3.248 · Cited by 109
Non‐alcoholic fatty liver disease
Alba, L. M., & Lindor, K. D. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01493.x · Cited by 108
Erbey, J. R., Silberman, C., & LYDICK, E. G. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00602-1 · Cited by 95
Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents.
Jick, S. S., Stender, M., & Myers, M. W. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.2067 · Cited by 65
Rajagopalan, R., Iyer, S. S., & Pérez, A. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00382.x · Cited by 23
Cited by
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes
Wilson, R. D., & Islam, M. S. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70739-9 · Cited by 289
Qudus B Aroyehun, A., Abdul Razak, S., Palaniveloo, K., Nagappan, T., Suraiza Nabila Rahmah, N., Wee Jin, G., Chellappan, D. K., Chellian, J., & Kunnath, A. P. (2020) · Foods · doi:10.3390/foods9091313 · Cited by 66
Chandrasekaran, K., Swaminathan, K., Kumar, S. M., Clemens, D. L., & Dey, A. (2012) · Integrative Biology · doi:10.1039/c2ib00155a · Cited by 18
Metadata
- Authors
- Harris, E. H.
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-07-01
- Volume
- 23
- Issue
- 3
- Pages
- 115-119
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- OpenAlex
- W2097398640
- Cited by
- 306
- References
- 28
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.